Bausch Health Companies (BHC) Current Deferred Revenue (2009 - 2012)
Bausch Health Companies (BHC) reported Current Deferred Revenue of $7.0 million for Q4 2012, down 44.99% on a YoY basis from $12.8 million in Q1 2012, and down 61.24% sequentially from $18.1 million in Q3 2012.
Bausch Health Companies (BHC) Current Deferred Revenue (2009 - 2012) Analysis & Trends
Bausch Health Companies (BHC) has 4 years of Current Deferred Revenue data on file, last reported at $7.0 million in Q4 2012.
- For the quarter ending Q4 2012, Current Deferred Revenue fell 44.99% year-over-year to $7.0 million; the trailing twelve-month figure through Dec 2012 stood at $7.0 million (down 44.99% YoY), and the FY2012 full-year result was $7.0 million, down 44.99% from the prior year.
- Current Deferred Revenue declined to $7.0 million in Q4 2012, from $18.1 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $23.3 million in Q3 2010 to a low of $7.0 million in Q2 2012.
- A 4-year average of $16.5 million and a median of $18.6 million in 2011 frame the typical range for Current Deferred Revenue.
- Peak annual rise in Current Deferred Revenue reached 23.02% in 2012, while the deepest fall reached 63.12% in 2012.
- Tracing BHC's Current Deferred Revenue over 4 years: stood at $21.8 million in 2009, then declined by 1.44% to $21.5 million in 2010, then tumbled by 40.6% to $12.8 million in 2011, then slumped by 44.99% to $7.0 million in 2012.
- Business Quant data shows BHC's Current Deferred Revenue at $7.0 million in Q4 2012, $18.1 million in Q3 2012, and $7.0 million in Q2 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 7.03 Mn |
| Sep 30, 2012 | 18.14 Mn |
| Jun 30, 2012 | 7.03 Mn |
| Mar 31, 2012 | 8.73 Mn |
| Dec 31, 2011 | 12.78 Mn |
| Sep 30, 2011 | 14.75 Mn |
| Jun 30, 2011 | 19.06 Mn |
| Mar 31, 2011 | 22.85 Mn |
| Dec 31, 2010 | 21.52 Mn |
| Sep 30, 2010 | 23.33 Mn |
| Jun 30, 2010 | 21.13 Mn |
| Dec 31, 2009 | 21.83 Mn |